Wecome Pharmaceutical Co Ltd (300878) — Capital Reinvestment Ratio
Wecome Pharmaceutical Co Ltd (300878) has a Capital Reinvestment Ratio of 0.01x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥50.89 Million) in capital expenditures (CN¥389.97K). Check Wecome Pharmaceutical Co Ltd (300878) tangible net worth to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Wecome Pharmaceutical Co Ltd Capital Reinvestment Ratio (2013–2023)
This chart tracks Wecome Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see Wecome Pharmaceutical Co Ltd (300878) cash flow conversion.
Annual Capital Reinvestment Ratio for Wecome Pharmaceutical Co Ltd (2013–2023)
Year-by-year Capital Reinvestment Ratio for Wecome Pharmaceutical Co Ltd from 2013 to 2023. See 300878 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.39x | CN¥58.29 Million | CN¥139.29 Million | ▲ +41.0% |
| 2022 | 1.70x | CN¥146.57 Million | CN¥248.44 Million | ▼ -52.4% |
| 2020 | 3.56x | CN¥42.81 Million | CN¥152.34 Million | ▲ +249.0% |
| 2019 | 1.02x | CN¥112.76 Million | CN¥114.98 Million | ▼ -37.7% |
| 2018 | 1.64x | CN¥105.57 Million | CN¥172.73 Million | ▲ +12.9% |
| 2017 | 1.45x | CN¥29.00 Million | CN¥42.04 Million | ▲ +202.7% |
| 2016 | 0.48x | CN¥100.15 Million | CN¥47.97 Million | ▼ -63.1% |
| 2015 | 1.30x | CN¥29.63 Million | CN¥38.48 Million | ▲ +46.9% |
| 2014 | 0.88x | CN¥46.01 Million | CN¥40.68 Million | ▲ +100.2% |
| 2013 | 0.44x | CN¥25.98 Million | CN¥11.48 Million | — |